Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

CTD-T AM 12.5/80/5 Tablet

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Telmisartan (80mg) + Amlodipine (5mg) + Chlorthalidone (12.5mg)

Overview CTD-T AM 12.5/80/5 Tablet

The combined medication CTD-T AM 12.5/80/5 Tablet effectively manages hypertension (high blood pressure) in cases where single-agent therapy proves insufficient. By reducing elevated blood pressure, it significantly lowers the risk of stroke and myocardial infarction. Administer this tablet with food, adhering to a consistent daily schedule as prescribed by your physician. Dosage is individualized based on your response and health status. Continuous use, as directed by your doctor, is crucial; discontinuation may increase cardiovascular event risk. This formulation includes a diuretic, potentially increasing urination; therefore, avoid taking it within four hours of bedtime. Consistent use maximizes therapeutic benefits, even during asymptomatic periods, as hypertension often presents without noticeable symptoms. Common side effects may include edema in the ankles, cephalalgia, vertigo, fatigue, and altered taste perception. Report any persistent, worsening, or bothersome side effects to your healthcare provider. Maintaining adequate hydration mitigates potential side effects such as myalgia, xerostomia, and polydipsia. Prior to commencing treatment, disclose any renal or hepatic impairment, and pregnant or breastfeeding individuals should seek medical guidance. Comprehensive disclosure of all concurrent medications, particularly those for hypertension or cardiac conditions, is essential. Regular monitoring of blood pressure, renal function, electrolyte balance, and glycemia ensures optimal treatment efficacy and safety.

Uses of CTD-T AM 12.5/80/5 Tablet

Elevated blood pressure

Major Benefits of CTD-T AM 12.5/80/5 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-T AM 12.5/80/5 Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

Common Side effects of CTD-T AM 12.5/80/5 Tablet:

  • Headache
  • Dizziness
  • Sleepiness
  • Edema (swelling)
  • Increased uric acid level in blood
  • Fatigue
  • Increased blood lipid level
  • Increased liver enzymes
  • Visual disturbance
  • Breathlessness
  • Muscle cramp
  • Gastrointestinal disturbance
  • Electrolyte imbalance
  • Increased glucose level in blood
  • Urticaria
  • Postural hypotension (low blood pressure)
  • Impotence

How to use CTD-T AM 12.5/80/5 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The CTD-T AM 12.5/80/5 Tablet should be administered with a meal.

How CTD-T AM 12.5/80/5 Tablet works:

The CTD-T AM 12.5/80/5 Tablet combines telmisartan, amlodipine, and chlorthalidone to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, act synergistically to dilate blood vessels, reducing blood pressure. Chlorthalidone, a diuretic, further lowers blood pressure by promoting fluid excretion and, in the long term, enhancing vascular relaxation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside CTD-T AM 12.5/80/5 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using CTD-T AM 12.5/80/5 tablets during pregnancy poses a confirmed risk to the fetus. A physician might exceptionally prescribe it in life-threatening emergencies where the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The use of CTD-T AM 12.5/80/5 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects of CTD-T AM 12.5/80/5 Tablet, including dizziness, headache, nausea, or fatigue, all of which can impact concentration.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using CTD-T AM 12.5/80/5 tablets. Dosage modification may be necessary; physician consultation is advised. This medication is generally unsuitable for such patients.

LiverLiverCAUTION

Patients with liver impairment should use CTD-T AM 12.5/80/5 Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. CTD-T AM 12.5/80/5 Tablets are contraindicated for those with severe hepatic dysfunction.

What if you forget to take CTD-T AM 12.5/80/5 Tablet :

Should you forget to take your CTD-T AM 12.5/80/5 Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About CTD-T AM 12.5/80/5 Tablet

LabelValue
Developing Habits No.
Treatment Category Heart
CTD-T AM 12.5/80/5 Tablet
207
MRP 252
17% off